Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 16, 2021

SELL
$387.35 - $450.26 $591,096 - $687,096
-1,526 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$314.62 - $411.0 $207,649 - $271,260
-660 Reduced 30.19%
1,526 $583,000
Q4 2020

Feb 16, 2021

BUY
$246.9 - $321.87 $365,165 - $476,045
1,479 Added 209.19%
2,186 $694,000
Q3 2020

Nov 16, 2020

BUY
$232.22 - $282.96 $73,845 - $89,981
318 Added 81.75%
707 $175,000
Q2 2020

Aug 14, 2020

SELL
$185.43 - $279.56 $1.49 Million - $2.24 Million
-8,019 Reduced 95.37%
389 $103,000
Q1 2020

May 15, 2020

SELL
$161.17 - $221.51 $132,320 - $181,859
-821 Reduced 8.9%
8,408 $1.59 Million
Q4 2019

Feb 14, 2020

BUY
$189.68 - $222.09 $1.75 Million - $2.05 Million
9,229 New
9,229 $2.03 Million

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.82B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track Lee Ainslie's Portfolio

Track Lee Ainslie Portfolio

Follow Lee Ainslie (Maverick Capital LTD) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.